Cognitive trajectories modeling of rare reversion in mild cognitive impairment

Published on Aug. 28, 2025Total Views: 44 times Total Downloads: 14 times Download Mobile

Author: QIN Yao ^1, ^2, ³ HUO Yanji ¹ ZHOU Jing ¹ ZHOU Yan ¹ HAN Hongjuan ⁴ CUI Jing ^1, ²  YU Hongmei ^1, ^2, ³

Affiliation: 1. Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan 030001, China 2. Shanxi Provincial Key Laboratory of Major Diseases Risk Assessment, Shanxi Medical University, Taiyuan 030001, China. 3. Ministry of Education Key Laboratory of Coal Environmental Pathogenicity and Prevention, Taiyuan 030001, China 4. Department of Mathematics, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, China

Keywords: Mild cognitive impairment Reversion Rare events Functional principal component analysis Multi-state model

DOI: 10.12173/j.issn.1005-0698.202503205

Reference: QIN Yao, HUO Yanji, ZHOU Jing, ZHOU Yan, HAN Hongjuan, CUI Jing, YU Hongmei. Cognitive trajectories modeling of rare reversion in mild cognitive impairment[J]. Yaowu Liuxingbingxue Zazhi, 2025, 34(8): 877-886. DOI: 10.12173/j.issn.1005-0698.202503205.[Article in Chinese]  Copied

Abstract
Full-text
References

Abstract

Objective To construct a dynamic framework for bidirectional transitions of mild cognitive impairment (MCI), quantifying both rare reversion and high-risk progression trajectories in cognitive dynamics.

Methods Patients diagnosed with MCI at baseline from 2005 to 2022 and completed at least two follow-up visits were selected from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and a retrospective cohort was constructed. Demographic information, APOEε4 genotype, and neuropsychological scales data were collected. Longitudinal cognitive assessments were functionally reconstructed using multivariate functional principal component analysis (MFPCA), with functional principal components (FPCs) extracted based on cumulative variance contribution rate (PVE>90%). Functional multi-state Markov models were developed to estimate inter-state transition intensities, year to year transition probabilities, and covariate effects.

Results Among 1,019 MCI patients (4,657 follow-up visits), 93 (9.1%) reverted to normal cognition, while 359 (35.2%) progressed to Alzheimer’s disease (AD). Longitudinal trajectory analysis revealed significant heterogeneity: progressive MCI > stable MCI > reverted MCI in the first functional principal component (MFPC1) scores. The transition intensity for MCI reversion (0.020) was approximately one-fourth of the AD progression risk (0.086), but the post-reversion cognitive re-impairment intensity was 0.138. Reduced MFPC1 (HR=0.993, 95%Cl: 0.991, 0.995) and elevated MFPC2 (HR=1.004, 95%Cl: 1.001, 1.007) were closely associated with MCI reversion.

Conclusion MCI exhibits marked heterogeneity in longitudinal cognitive trajectories. Although reversion is rare, reversed patients remain at high risk of cognitive re-impairment.

Full-text

Please download the PDF version to read the full text: download

References

1.Yang X, Wang Z, Li H, et al. Polygenic score for conscientiousness is a protective factor for reversion from mild cognitive impairment to normal cognition[J]. Adv Sci (Weinh), 2024, 11(29): e2309889. DOI: 10.1002/advs.202309889.

2.Qin Y, Han H, Li Y, et al. Estimating bidirectional transitions and identifying predictors of mild cognitive impairment[J]. Neurology, 2023, 100(3): e297-e307. DOI: 10.1212/WNL.0000000000201386.

3.Alsefri M, Sudell M, García-Fiñana M, et al. Bayesian joint modelling of longitudinal and time to event data: a methodological review[J]. BMC Med Res Methodol, 2020, 20(1): 94. DOI: 10.1186/s12874-020-00976-2.

4.Papageorgiou G, Mauff K, Tomer A, et al. An overview of joint modeling of time-to-event and longitudinal outcomes[J]. Annu Rev Stat Appl, 2019, 6: 223-240. DOI: 10.1146/annurev-statistics-030718-105048.

5.Weaver C, Xiao L, Lu W. Functional data analysis for longitudinal data with informative observation times[J]. Biometrics, 2023, 79(2): 722-733. DOI: 10.1111/biom.13646.

6.Gomon D, Putter H, Fiocco M, et al. Dynamic prediction of survival using multivariate functional principal component analysis: a strict landmarking approach[J]. Stat Methods Med Res, 2024, 33(2): 256-272. DOI: 10.1177/09622802231224631.

7.Yuan M, Xu C, Fang Y. The transitions and predictors of cognitive frailty with multi-state Markov model: a cohort study[J]. BMC Geriatrics, 2022, 22(1): 550. DOI: 10.1186/s12877-022-03220-2.

8.Xue HP, Hou P, Li YN, et al. Factors for predicting reversion from mild cognitive impairment to normal cognition: a Meta-analysis[J]. Int J Geriatr Psychiatry, 2019, 34(10): 1361-1368. DOI: 10.1002/gps.5159.

9.Salemme S, Lombardo FL, Lacorte E, et al. The prognosis of mild cognitive impairment: a systematic review and Meta-analysis[J]. Alzheimers Dement (Amst), 2025, 17(1): e70074. DOI: 10.1002/dad2.70074.

10.Malek-Ahmadi M. Reversion from mild cognitive impairment to normal cognition a Meta-analysis[J]. Alzheimer Dis Assoc Disord, 2016, 30(4): 324-330. DOI: 10.1097/WAD.0000000000000145.

11.Canevelli M, Grande G, Lacorte E, et al. Spontaneous reversion of mild cognitive impairment to normal cognition: a systematic review of literature and Meta-analysis[J]. J Am Med Dir Assoc, 2016, 17(10): 943-948. DOI: 10.1016/j.jamda.2016.06.020.

12.Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis[J]. Neurology, 2012, 79(15): 1591-1598. DOI: 10.1212/WNL.0b013e31826e26b7.

13.McGirr A, Nathan S, Ghahremani M, et al. Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late-onset neuropsychiatric symptoms[J]. Neurology, 2022, 98(21): e2132-e2139. DOI: 10.1212/WNL.0000000000200256.

14.McWhinney SR, Hlinka J, Bakstein E, et al. Principal component analysis as an efficient method for capturing multivariate brain signatures of complex disorders-ENIGMA study in people with bipolar disorders and obesity[J]. Hum Brain Mapp, 2024, 45(8): e26682. DOI: 10.1002/hbm.26682.

15.Lin L, Ni L, Wang X, et al. Longitudinal cognitive change and duration of Alzheimer's disease stages in relation to cognitive reserve[J]. Neuroscience, 2022, 504: 47-55. DOI: 10.1016/j.neuroscience.2022.09.017.

16.Niyogi PG, Lindquist MA, Maiti T. A tensor based varying-coefficient model for multi-modal neuroimaging data analysis[J]. IEEE Trans Signal Process, 2024, 72: 1607-1619. DOI: 10.1109/tsp.2024.3375768.